The Readout Loud
STAT
Add to My Podcasts
Episodes
About
Reviews
Promote
Episode 32: Fake friends at the FDA, cancer counter-narratives, and biotech's bear turn
22 minutes
Posted Oct 11, 2018 at 8:13 pm.
0:00
22:47
Add to My Queue
Download
MP3
Share
episode
Share at current time
Show notes
Is the next big idea in oncology a bust? What does "successful" mean exactly? And why does Wall Street hate biotech all of a sudden?
Previous
Episode 31: Nobel snubs, millenial founders, and a new kind of lightning round
Next
Episode 33: Drug prices on TV, immortal blockbusters, and genetic privacy
← See all 424 episodes of The Readout Loud
